What Does It Take to Develop a New Drug for COVID-19?


Steve Chamow

Thursday, April 16th, 6-7pm PT / 9-10pm ET
# people have already signed up
This event is sold out, but if you sign up for the waitlist, we'll let you know if spots become available.
You're on the waitlist now!
Oops! Something went wrong while submitting the form. Please email us at info@speakeasy.com to join the waitlist.
What Does It Take to Develop a New Drug for COVID-19?
No items found.


Join Dr. Steve Chamow as he explains what it will take for drug companies to mitigate the impact of coronavirus. Event Description: We are experiencing a pandemic that is affecting us as never before in our lifetimes. What is this virus and why is it having such a profound impact? What will it take to make new drugs to treat it? Join Dr. Steve Chamow as he explains how pharmaceuticals are developed and regulated in the United States today and what strategies are being applied to bring new medicines and vaccines to market during this public health emergency. Event Location: This event will take place online via Zoom, a free video-conferencing tool. New to Zoom? After you buy your ticket, you'll receive an email with step-by-step instructions on how to use it, and you'll be a pro in no time! Steve’s Bio: Dr. Steven Chamow has over 30 years of experience in biopharmaceutical product development. Since 2008, he has served as president of Chamow & Associates, Inc., a consulting group working with biotechnology companies to design and implement strategies to develop new therapeutic products. In his career, he has contributed to the development of three marketed biologics (Avastin, Natrecor, Vectibix). Prior to his current position, he was Senior Vice President, CMC, at Intradigm Corporation, a private biopharmaceutical company focused on developing RNAi therapeutics (acquired by Silence Therapeutics). Dr. Chamow was Vice President, Process Sciences, at Genitope Corporation and at Abgenix, Inc., (acquired by Amgen) where he built the company’s process sciences department and helped to lead the design and construction of Abgenix’ award-winning production facility in Fremont, CA (sold by Amgen to Boehringer-Ingelheim to become its first North American production facility). Before Abgenix, he served as Director of Biopharmaceutical Development at Scios, Inc. (acquired by J&J), and as a scientist and senior scientist in process development at Genentech, Inc. (acquired by Roche). Dr. Chamow was educated at the University of California (UC Santa Cruz, B.A. in biology; UC Davis, Ph.D. in biochemistry), and completed postdoctoral training at the National Institutes of Health in Bethesda, MD. He is author or co-author of more than 50 scientific publications and patents and co-editor of two books. About Speakeasy: Speakeasy offers intimate events with compelling speakers and performers online via Zoom. Learn more about Speakeasy and check out a list of all of our events.

What to expect at this event